Donanemab marks start of “new story” in Alzheimer’s research

Professor Craig Ritchie has told an international Alzheimer’s conference that phase 3 clinical trial results for donanemab, the antibody drug designed to target and clear the amyloid plaques considered key to progression of Alzheimer’s disease, reveal the drug’s “profound” clinical effect. 
Read more

Chief Scientist calls for more research volunteers

With the publication of Scotland's new dementia strategy, the government's Chief Scientist for Health, Professor Anna Dominiczack says it is now an important time to help make life-changing discoveries – encouraging Scots to volunteer for research into progressive brain conditions.
Read more

Scotland hosts second world brain health summit

Professor Craig Ritchie, CEO of Scottish Brain Sciences co-hosts the second international brain health summit in St Andrew's, bringing together experts across the NHS, academia, and industry for a two-day conference.
Read more

The SBS Blog – June 2023 Recap

With visits to both Boston, Massachusetts for the BIO Convention, as well as San Francisco, California, for an exciting Life Sciences reception, June 2023 was a big month for Scottish Brain Sciences. And one that also promised big things on the horizon!
Read more
Professor Craig Ritchie, CEO Scottish Brain Sciences.Scottish Brain Sciences

A Strategy for Brain Health

Scottish Brain Sciences Founder and Chief Executive, Professor Craig Ritchie, welcomes the Scottish Government's new dementia strategy and says Scotland can now complete the picture with a separate national Brain Health Strategy.
Read more
Professor Craig Ritchie, CEO Scottish Brain Sciences.Scottish Brain Sciences

The hope for a life-long healthy brain

Professor Ritchie spoke with The Times about the drive to advance research at a faster pace than manageable within the NHS.
Read more

Research and publications